Table 3.
Detection rate of DR lesions on WF CFP plus UWF SS-OCTA vs. WF CFP plus FFA.
| Detection rate of DR lesions on WF CFP plus UWF SS-OCTA (24 × 20mm) vs. WF CFP plus FFA (eyes, %) | ||||
|---|---|---|---|---|
| DR lesions | WF CFP plus UWF SS-OCTA | WF CFP plus FFA | p-value | κ value |
| MA | 138/153(0.90) | 141/153(0.92) | 0.250 | 0.878 |
| IRH | 128/153(0.84) | 132/153(0.86) | 0.125 | 0.898 |
| NPAs | 112/153(0.73) | 105/153(0.69) | 0.039 | 0.858 |
| IRMAs | 104/153(0.68) | 98/153(0.64) | 0.070 | 0.884 |
| VB | 67/153(0.44) | 56/153(0.37) | 0.052 | 0.635 |
| NVE | 42/153(0.27) | 41/153(0.27) | 1.000 | 0.950 |
| NVD | 14/153(0.09) | 12/153(0.08) | 0.500 | 0.916 |
| VH/PRH | 22/153(0.14) | 23/153(0.15) | 1.000 | 0.974 |
DR, diabetic retinopathy; MA, microaneurysms; IRH, intraretinal hemorrhage; NPAs, non-perfusion areas; IRMA, intraretinal microvascular abnormalities; VB, venous beading; NVE, neovascularization elsewhere; NVD, neovascularization of the optic disc; VH/PRH, vitreous hemorrhage or preretinal hemorrhage.